At a glance
ClinicalIndex Comparison RecordN/ACompleted· 885 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Prospective Evaluation of a Predictive Test of Late Toxicities After Radiotherapy by the Rate of Radiation Induced CD8 T-Lymphocyte Apoptosis: Application to Breast and Prostate Cancers.
Institut du Cancer de Montpellier - Val d'Aurelle·observational·Posted May 5, 2009·Updated Feb 5, 2026
In Brief
An observational study for Breast Cancer and Prostate Cancer. Completed, enrolled 885 participants across 1 site.
Detailed Summary
The primary objective of this study is to evaluate the prediction of late toxicity by the radiation induced CD8 T-lymphocyte apoptosis
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Prostate Cancer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2006
First PostedMay 2009
Primary CompletionDec 2015
Study CompletionOct 2019
TodayJul 2026
First PostedMay 5, 2009
Enrollment StartJun 1, 2006
Primary CompletionDec 1, 2015
Study CompletionOct 29, 2019
TodayJul 2, 2026
Enrollment to primary: 9.5 yearsPosted 17.2 years ago